8847
-
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
(600,779) Views
Editor in Chief Professor Ming Zou
1178-7007
LetterPotent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
Kapoor S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:121-123
11 May 2012
Review
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
AlMaatouq MA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:109-119
01 May 2012
Review
Clinical features and treatment of maturity onset diabetes of the young (MODY)
Gardner DS,Tai ES
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:101-108
01 May 2012
Review
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
Dincer UD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:89-99
05 April 2012
Review
Obesity: considerations about etiology, metabolism, and the use of experimental models
Pereira-Lancha LO, Campos-Ferraz PL, Lancha Junior AH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:75-87
10 April 2012
Review
Uncovering undetected hypoglycemic events
Unger J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:57-74
08 March 2012
Original Research
Negative association of acetate with visceral adipose tissue and insulin levels
Layden BT, Yalamanchi SK, Wolever TMS, Dunaif A, Lowe Jr WL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:49-55
28 February 2012
Short Report
Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice
Nikoulina SE, Fuchs D, Moheno P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:43-47
24 February 2012
Original Research
Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials
MacConell L, Brown C, Gurney K, Han J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:29-41
20 February 2012
Original Research
Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
Vinson JA, Burnham BR, Nagendran MV
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:21-27
18 January 2012
Review
Insulin detemir for the treatment of obese patients with type 2 diabetes
Hollander PA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:11-19
10 January 2012
Review
Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
Uy J, Fogelfeld L, Guerra Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:1-10
10 January 2012
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
